about
Glia and alpha-synuclein in neurodegeneration: A complex interactionTowards translational therapies for multiple system atrophyMesenchymal stem cells in a transgenic mouse model of multiple system atrophy: immunomodulation and neuroprotectionTargeted overexpression of human alpha-synuclein in oligodendroglia induces lesions linked to MSA-like progressive autonomic failure.The neuropathology, pathophysiology and genetics of multiple system atrophy.A randomized trial of mesenchymal stem cells in multiple system atrophy.Multiple system atrophy: current and future approaches to managementTreatment of multiple system atrophy using intravenous immunoglobulin.Insights into the evolutionary features of human neurodegenerative diseases.Modelling progressive autonomic failure in MSA: where are we now?Involvement of Peripheral Nerves in the Transgenic PLP-α-Syn Model of Multiple System Atrophy: Extending the PhenotypeSymptoms and quality of life in late stage Parkinson syndromes: a longitudinal community study of predictive factorsThe natural history of multiple system atrophy: a prospective European cohort studyNeuromuscular and systemic presentations in adults: diagnoses beyond MERRF and MELASNeuropathology underlying clinical variability in patients with synucleinopathies.Management approaches to hypertension in autonomic failure.Multiple system atrophy of the cerebellar type: clinical state of the art.Neuropathology of multiple system atrophy: new thoughts about pathogenesis.Multiple system atrophy: genetic or epigenetic?An update on the cerebellar subtype of multiple system atrophy.Fragile X-associated tremor/ataxia syndrome: phenotypic comparisons with other movement disorders.Synucleinopathies: common features and hippocampal manifestations.Does the Type of Multisystem Atrophy, Parkinsonism, or Cerebellar Ataxia Impact on the Nature of Sleep Disorders?Potential Modes of Intercellular α-Synuclein Transmission.SUMO-1 is associated with a subset of lysosomes in glial protein aggregate diseases.Cost-of-illness in multiple system atrophy and progressive supranuclear palsy.Oligodendroglial alpha-synucleinopathy and MSA-like cardiovascular autonomic failure: experimental evidence.Applying bioinformatics to proteomics: is machine learning the answer to biomarker discovery for PD and MSA?The Diagnosis and Natural History of Multiple System Atrophy, Cerebellar Type.Potential clinical utility of multiple system atrophy biomarkers.Depression and anxiety in multiple system atrophy.Behavioral and histological analysis of a partial double-lesion model of parkinson-variant multiple system atrophy.Autonomic symptoms in idiopathic REM behavior disorder: a multicentre case-control study.Multiple System Atrophy: Many Lessons from the Transcriptome.Cognition in a multiple system atrophy series of cases from Argentina.Evaluation of autonomic functions of patients with multiple system atrophy and Parkinson's disease by head-up tilt test.Multiple System Atrophy: An Oligodendroglioneural Synucleinopathy.The Bulbocavernosus Reflex in the Differential Diagnosis of Multiple System Atrophy with Predominant Parkinsonism and Parkinson's Disease.Cystatin C is differentially involved in multiple system atrophy phenotypes.
P2860
Q26851153-1D12AC5F-659C-4342-8F0B-7FFAC5E39EF4Q33797532-8A47A4AC-A675-4AC8-A663-BE511F73C398Q33916838-54A65048-B5F2-4EE7-B711-9FEFA24D01E9Q34032393-9B749083-8598-4F05-8111-A5E7FE43BF1CQ34231585-BB49DC15-2915-4937-83E5-DEB6BF092530Q34290126-8D66913E-2776-48E9-9220-472936E3FEB7Q34409502-333B0962-7FD7-4CE9-B2A9-5DA65162B5C3Q34463907-8495FD17-5BB0-4DE0-88E3-E6DEAE57C981Q34465001-FCF3DAF9-0274-4BFA-9192-9A7A26E95DB3Q34626244-DF3BA780-8094-4659-B8C1-882D389290C6Q35819324-255E0794-8E9F-41C0-9255-F60959E1ADF6Q36380930-990B41F3-7FDD-484B-BCA7-420261F07659Q36637012-B57F34FC-4748-49DC-96C4-F359070B3E51Q36762830-8F6FAFAD-2406-44C4-9053-389B1E12BF85Q37896515-E4330457-41BA-4FC5-BFFA-C5FB40F30DC3Q38026735-D8619359-DCD4-44EE-848B-69C5A33F80C3Q38194974-7CB555A4-8B94-4629-B2C6-716CCBDA2329Q38258246-7636B6E3-6E49-431D-A572-EF1C67C2EA05Q38303573-2F46E0AC-912A-4ED6-A588-D3E4BDA49B73Q38578814-D6ACAC62-C0AB-47FE-B123-0C83CAD87D6DQ38896237-0DAB88E2-4522-4CBE-95E2-53703D054500Q39003423-86E9998A-4672-409F-AB12-0F6A1BC7D4D5Q39008899-49EC60D7-95EB-4781-87CB-98DB581A8D11Q39152836-6438BE03-4FBE-4331-9B08-B56DCCE44F0FQ39228154-72F3E6F3-8E1C-4EA3-AF59-091548242E65Q39762141-42E17DBA-E043-4D36-ACC5-F4F271B135DAQ42266864-07261C30-E9DF-401A-A575-B67C9130BDE8Q43434112-51DAD129-3CAA-4D28-82E3-A8890F52104BQ44457611-B304B129-6B3D-49ED-AC9A-481B4490D1B4Q47663712-9DB3DA74-E019-45EE-9ECB-874DBB5B3374Q47685565-AE868CD3-22AD-44FF-9656-EE6CC1B3095DQ47925610-BD825C6F-FE79-40CA-9152-3939508F2399Q48116076-77B808B8-C5AD-4F8A-A664-4B5AEB753643Q48168325-3B7A4744-3279-4341-B003-F3C5EF68FC61Q48187603-09C21020-3659-4648-AABA-330A2A8447CAQ48219979-A552C941-90BE-4528-A01E-DEF56C53BFF1Q49562668-AC7933B7-C34D-4AB3-9D67-439687CB1D8CQ49592917-9CC58AA8-5265-429D-B710-1FCA09C4DC84Q50477602-826C65F5-25D7-4D70-BA2F-F5A89B6B5067
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Recent developments in multiple system atrophy.
@en
Recent developments in multiple system atrophy.
@nl
type
label
Recent developments in multiple system atrophy.
@en
Recent developments in multiple system atrophy.
@nl
prefLabel
Recent developments in multiple system atrophy.
@en
Recent developments in multiple system atrophy.
@nl
P2860
P1433
P1476
Recent developments in multiple system atrophy
@en
P2093
Nadia Stefanova
P2860
P2888
P304
P356
10.1007/S00415-009-5173-8
P577
2009-05-27T00:00:00Z